LDN Video Interviews and Presentations

Radio Show interviews, and Presentations from the LDN 2013, 2014, 2016, 2017, 2018 and 2019 Conferences

They are also on our    Vimeo Channel    and    YouTube Channel

Pharmacist Masoud Rashidi, LDN Radio Show 11 Dec 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood:  I'd like to welcome my guest, Dr Masoud Rashidi.  He was from California, the owner with his wife, Dr Anna.  They own their own compounding pharmacy in Folsom.  Thanks for joining us today, Masoud. 

Masoud Rashidi:  Thank you, Linda, for having me on the show.

Linda Elsegood:  Could you tell us what made you decide to get into pharmacy?

Masoud Rashidi:   It started back in high school.  My dad knew a pharmacist, and I was able to shadow with him for a day.  It was interesting how you can help people and get to know them.  I wanted to pursue pharmacy after that.

Linda Elsegood:  Wow.  That's amazing, isn't it?  So how long have you been a pharmacist now?  Did they know about LDN?

Masoud Rashidi:  I've been a pharmacist for 15 years now, since 2004.  That's when I graduated from Western University of Health Sciences in Pomona, California.  That's where I received my doctorate degree and started working a few months thereafter.  I started working at a chain, like everybody else out of school.  They did not know about LDN.  After a few years, I started working at a chain in California.  A couple of years later, I decided to explore, because there was a need for a compounding pharmacy in town.  There was none available at the time.  So, we had rotations back to school to learn about compounding, but we still didn't know about LDN until I began compounding and started our own company in 2007.  That's where we became involved in compounding LDN.

Linda Elsegood:  So, in your pharmacy, what forms of LDN do you offer?

Masoud Rashidi:  We provide a few different ones.  Mainly, we do capsules in many different dosages.  We also do lozenges.  We've compounded a topical, such as a transdermal application; also a liquid, both in aqueous solution or oil, depending on the situation  The kid may take the oil or not, so we go from there, depending on what flavors we can incorporate into the different formation.  We pretty much do every possible dosing that is available right now.

Linda Elsegood:  And what strength do you normally start with?  Do you do a micro-dose?

Masoud Rashidi:  Yes, we do micro-dosing; actually we've done a few of them.  Our most common one, of course, is the typical dosing, 1.5 mg, 3.0 mg, and 4.5 mg, but the last few years everything has changed.  We’re doing so many different doses every day.  We've done from 0.1 mg all the way to 9.0 mg.

With micro-dosing, we do from 1 microgram to 5, 10, depending on where are going to end up with that particular patient and their needs.  We've been doing both, like several different dosing, and we send our products to third-party testing to ensure potency and quality.

Linda Elsegood:  Having spoken to so many pharmacists, it's very difficult to say that one microgram of LDN is very difficult to know.  It's very hard to prove.  You have to find the right people to have it tested.  Lots of people, I'm sure, who take LDN are not aware of all the efforts that compounding pharmacies must go through.  Would you like to tell us a bit about that? 

Masoud Rashidi:   We received two different chemicals of Naltrexone from a couple of different wholesalers.  Then we send it for testing after compounding to determine the best one to use.  It’s not a requirement to do all this testing, but we go above and beyond to make sure we get the right dosing.  We send samples to the third-party lab to be tested to see if it is within range.  Legally, you can have 10% variation on the capsules, but in our lab, we like to keep it less than 3% to be even more accurate.  When we send it out, we tried to keep it less than 5%, especially when you get to low doses.  Ten per cent is a lot of variation when dealing with one microgram, so we try to keep that even lower than what's legally allowed to ensure higher quality.  In the past, they've rejected a chemical because it had too much water content.

Linda Elsegood:  What kinds of doctors are you dealing with?  Naturopathic doctors, pain specialists, MD’s, and other prescribers?

Masoud Rashidi:  Yes, you are right on.  One of our biggest prescribers is a nurse practitioner who specializes in women's health and sees many people with Hashimoto's and autoimmune.  We have an MD, after going to the LDN Research Trust Conference a few months ago, has become big on LDN.  We have a few naturopaths.  I go to different doctor's offices and educate them on LDN.  In California, unfortunately, a lot of naturopaths cannot prescribe; they must have oversight MD’s.  They must find a naturopath who can prescribe it because not every naturopath in California can do so.  We do have MDs, nurse practitioners, a variety of different doctors, even paediatrics.  One of our best cases was an autism patient, with a prescribing MD.  It was amazing.  Every time I think about it I get goosebumps because of what happened.  A few days later, the mom calls and says, “Oh, my kid is actually communicating with two siblings!”  It was three days later at 0.1 milligrams.  It's been about three months, and she's one of the best advocates for LDN.  She calls us all the time.  This child is talking more and more with the siblings and the parents and having eye-to-eye contact.  The mom said it was life-changing, and that's what we hear all the time.  My life has changed after LDN.  It's rewarding when you hear those words, and that's why we keep doing what we're doing.  We continue to conduct seminars for the public and for the doctors to increase awareness.  It's been very good for the patients, and our goal is to increase awareness on how great it is and how it can help in so many ways, especially with all the research articles available now.

Linda Elsegood:  What case studies do you have, feedback from patients, and their conditions?

Masoud Rashidi:  One of the biggest ones we get is RA or rheumatoid arthritis.  They get a lot of good response.  After a week or two, they can move their fingers, and they don't have much pain.  They've tried all these different drugs, and nothing works.  Now after a week or two, it's amazing sometimes.  For some patients, it takes a few months, but sometimes, within a week they call you back, and it's like, “Oh my God, what is this? This is working amazingly.” 

One amazing result was an MS (multiple sclerosis) patients.  I was brand new to compounding, six months.  We didn’t have that many employees, so we knew every patient that came in the door. He comes in with a wheelchair.  He’s tried everything.  We consulted with MS experts, and that's how we started with LDN, just speaking with them.  I kid you not, three months later, he comes in, WALKS into the pharmacy.  I'm like, whoa!  He was in tears.  He says, “I’ve been in a wheelchair for so many years.  I've tried all these drugs, and nothing has worked.  This has been amazing.”  That's when we started promoting LDN more, talking to different doctors about it.  We get to a lot of good feedback like that.  There are just too many of them to share.

Linda Elsegood:  What about patients with GI problems?  Have you had any feedback from those?

Masoud Rashidi:  Actually, we’ve seen IBS, IBD, Crohn’s disease, and things like that having really good results.  Of course, as we all know, not every drug is going to do 100% for every patient.  But we’ve had about 80% good results.  The funny part is that they’ve tried all other drugs that are commercially available, and nothing has worked.  At this point, they contact us.  After so many doctors, so many drugs, and they come in and then have good success with LDN.  Every time we do our seminars, people come in and ask, “Oh, would it work for this?”  So, we start researching.  Our latest question, Mom called us and said, “Okay, my daughter's addicted to narcotics.  They put her on Suboxone.  What can I do with LDN?  She's now more addicted to Suboxone than she was addicted to narcotics.”  We're researching that right now.  It's amazing how one drug can treat so many different conditions.

Linda Elsegood:  Definitely.  Still talking about GI, do you have any patients using it for SIBO, (small intestinal bacterial overgrowth)?

Masoud Rashidi:  I've read a lot about it.  We have a patient wanting to try it, but the doctor was not willing to prescribe it.  We referred care to this new physician.  This is our first case, and we'll find out hopefully soon.

Linda Elsegood:  What about Lyme? Is that something you've seen 

Masoud Rashidi:  Lyme…yes, we have.  So many people go undiagnosed, and then they get diagnosed, and they don’t know what to give them.  Then they're on pain meds and stuff like that.  We had a Lyme patient, we talked to her doctor and put her on LDN.  It has helped her a lot with her symptoms.  We've had quite a few patients, but she was a really severe case with multiple issues.  About two and a half months later she was off many of her medications, and she was feeling much better.  She could resume driving, not being on all these different drugs.  Previously, she was depressed.  Now she gets up, and she can do things in the morning.  We’ve had other cases with very good results as well.

Linda Elsegood:  Okay. And have you got vets around who prescribe LDN for animals?

Masoud Rashidi:  I've talked to quite a few veterinarians in town.  We’re writing a protocol on how to use LDN for pets.  One veterinarian has used it, and it helps with all the issues that humans have.  There are a lot of articles on that.  We've been starting them on the lower doses.  We do make it mostly liquid in an oil suspension so that it lasts longer.  We have had a few now.  The vets have been very happy, and the owners have been happy.  The dog had arthritic pain and could not move as much.  We gave him the LDN, the veterinarians prescribed it, and then a month or so later the dog is doing much better.  Veterinarians talk to each other.  We get more questions from different veterinarians every day and hope that we can get more awareness of LDN for pets.  It works for them.  We've seen results, few, not many, but I've read a lot of research studies on it.  I am hoping that it's going to become more popular sooner rather than later in the pet world, too.

Linda Elsegood:   Right.  It's all to do with raising awareness and making the doctors feel comfortable.  Not surprised that you have so many MD’s prescribing LDN.  Again, they are traditionally trained and many of them take some convincing to look outside the box.  You were saying ND’s in your area often can't prescribe the LDN.  What about physician assistants?  Are they allowed to prescribe?

Masoud Rashidi:  Oh yeah, they do.  We have one who's a big proponent of it because he's seen really good results.  He's a functional medicine PA.  He involved the doctor and everybody else.  It's contagious when you see good results.  They tell each other, and they start calling it in.  Yes, we have quite a few PA’s that prescribe.  Not as many as I want.  They're coming on board because we’re holding seminars in large scale now.

Linda Elsegood:  Yes, PA’s tend to have more time to listen to patients than doctors.  It's amazing what these service providers are doing.  We'd be lost without them.  

Masoud Rashidi:  You're absolutely right.  As far as they have more time to spend with the patient because doctors have a lot of other things going on at the same time. 

Linda Elsegood:  When you have a chronic disease, let's say MS or lupus, even fibromyalgia, trying to get the diagnosis isn't easy.  And then you’ve got to find somebody to help you to get the right treatment because obviously everybody is different.  It also helps to have that patient, doctor and pharmacist relationship, doesn't it?  You know, the triangle.  Presenting LDN to more doctors and letting them know that you're there to answer any questions or queries they may have I would think helps them become more confident in prescribing LDN.

Masoud Rashidi:  That's true.  Even in our patient's seminar, we had last month, we had four prescribers show up at the seminar that was for the patient.  It was very interesting.  In future seminars, we may broadcast on Facebook Live or somewhere, so more people can be reached who cannot come in.  All our seminars are free.  We do this for awareness.  We have people come in and share their stories.  Patients talk to each other, and then they start getting up and talking to the whole group.  That's amazing, too, because then they are hearing from the patient, not from us.

Linda Elsegood:  Of course, patients, as soon as they learn about LDN, they then go and find a doctor or educate their own doctor.  I think patients also play a big part in raising awareness of LDN, especially when they have good results.

Masoud Rashidi:  Exactly.  We give them a whole binder.  We've seen that patient take those binders to their doctor and show them some of the research studies, because some doctors are still thinking of Naltrexone as a whole dose Naltrexone and they're like, “Oh, you don't need it.”  We tell them, take this to your doctor, and that has helped.  You are absolutely right.  Patients are the best advocate for this whole thing because they see results.

Linda Elsegood:  We’ve come to the end of the show.  Thank you so much for having been my guest today.  It really was a pleasure speaking with you.

Masoud Rashidi:  Thank you for having us, and it was a pleasure speaking with you.  

Linda Elsegood:  Thank you. 

This show is sponsored by Doctors Masoud and Anna Rashidi.  They graduated in 2004 from Western University with a Doctor of Pharmacy degrees. Soon after in 2007, they opened the PCAP accredited Innovative Compounding Pharmacy located at 820 Wales Drive, Suite 3, Folsom, California  95630.  To better serve the community, for more information, please call (866) 470-9197 or visit www.icpfolsom.com.  

Any questions or comments you may have, please email me.  Linda, contact@ldnresearchtrust.org  I look forward to hearing from you. Thank you for joining us today.  We really appreciate your company.  Until next time, stay safe and keep well.

Pharmacist John Herr, LDN Radio Show 21 Nov 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today I'm joined by pharmacist John Herr, and he's from New Jersey in the US. Thanks for joining me today. John. 

John Herr: Oh, you're welcome. Glad to be able to spend this time with you. 

Linda Elsegood: Good. And I didn't mention where you're from and you're from Town and Country Compounding. So first of all, tell us how you got into working as a pharmacist.

I mean, had you always been interested in pharmacy as a child? 

John Herr: Well, I've always been interested in pharmacy, and I've always been interested in like natural medicine or integrative, we now call it integrative medicine or functional medicine. But back in the day, I think we called it natural, and I was just lucky I went to a think John's University in New York City and, and I made the acquaintance of a physician who was, she was actually a pioneer in bringing natural or bioidentical progesterone into the United States. So back then, I was still in pharmacy school and, and I started to like working with patients with bioidentical progesterone.

And it just kinda changed the way that kind of, I thought as a pharmacist and I, I really consider myself like an integrative pharmacist now. So low dose naltrexone to me was just a natural progression of, you know, my knowledge and my interests.  

Linda Elsegood: so how long would you say that you've been compounding LDN now.

John Herr: Oh my God, I think it's gotta be around two, maybe around 2000 or 2002. You know, just when it was really becoming, you know, old people were starting to understand it. It's interesting. One of my patients, when I had my retail pharmacy, she ended up writing a book about it, about her husband.

It was called “Up the Creek with a Paddle”. and Mary Bradley and I, she had been in my pharmacy and her husband at the time had MS, and we were talking about, and I recommended the low dose naltrexone to her, and then she went and sought out Dr Bahari. And you know, she started, you know, they started her husband on that for his MS and that, that's where my original interest was.

And she ended up writing the book, you know, “Up the Creek with a Paddle”. And my biggest claim to fame is I’m mentioned in the book as the one who told her about researching low dose naltrexone. And then. Subsequently, after that, I became acquainted with a gentleman named Fritz Bell, who started a website, good shape because back then people were just, you know, going on the internet and they were buying the 50-milligram tablet and trying to, you know, create their own.

So, you know, Fritz had a big interest in that and, I filled prescriptions for his wife, but I also filled prescriptions for people where Fritz donated it to them because he wanted people to be able to take the medication and not have to compound their own.

So if they qualified to his standards, we would make it up and send it out, no charge. So those patients could start on the low dose naltrexone. So I go back way to the beginning. And you know, I think back then we just thought of low dose naltrexone and honestly for MS. But you know, subsequently, over the years we've just learned, you know, how vast different disease states we can treat and manage with low dose naltrexone.

Linda Elsegood: And what forms do you compound LDN in? 

John Herr: Well, the most typical is a capsule, uh, which we do an immediate release capsule. Um, we're in the process of buying a, uh, switching over to like a tablet so that we can, uh, you know, meet the need, you know, with a tablet machine. But right now we make capsules. We also make, um, we've actually done a transdermally.

I treat a lot of children on the autistic spectrum disorder. You know, we've had to do it in sublingual liquid for some of the children. Uh, we have a couple of patients on it right now, believe it or not, for a vaginal cream. We've also used it transdermally for like neuropathic pain on different areas of the body.

And I've been researching some articles recently. I'm using it as an Automic drop for chronic dry eye, but I've been talking to a couple of different integrative physicians about using it. But, uh, up to this point, we haven't have anybody try it for the ophthalmic. But I'll, I'll keep everybody appraised when we do because there is, there's a lot of interest in using it for that function as well.

Linda Elsegood: And I know that there are some dentists that are also using LDN, so that's another interesting one. And how about ultra-low-dose naltrexone? Is that used in your area that you cover? , 

John Herr: yeah, we have some patients on it. We also do a lot of pain management. We have, uh, we've managed intrathecal pumps in the home.

So I worked with a lot of doctors, pain doctors and I actually work with a doctor, a doctor speaking at the next conference in Portland. And so I work with his patients, and we have to start a lot lower on his patients because many of them are on opioids. And I've worked with some pain physicians where we've actually compounded as low as 100 microgram capsules because I think you really need a physician who is trained in pain management because they're actually weaning the patient off of the opioids as they're bringing the LDN up very gradually.

And it's a real balancing act because. You are going to detox that patient. So that's not something I would recommend for you, you know, like a general practice physician to you. Um, but we do have a lot of patients that are using it that way where they're getting off of this. And then I just, we just get tremendous feedback when they're off of the opioids, how they're then maintaining the pain with these, with, you know, LDN that we consider, you know, on that standard dose that we consider for pain.

But it is a little tricky to get them off of those. Um. Yeah. Off the opioid, while you're bringing the low dose naltrexone up to the appropriate dose. 

Linda Elsegood: I mean, I've interviewed several pain specialists, and they seem to be using 0.001 which must be like a grain of sugar of naltrexone, and they explain, sorry, 

John Herr: carry on.

Zero one micrograms, 

Linda Elsegood: Linda. Yes. Wow. Yeah, so 

John Herr: I mean, 

Linda Elsegood: exactly, but by doing that and using it alongside the opioid, it makes the opioid stronger so that they can reduce the opioid and slowly increase the by 0.001 sorts of the thing. They do like sort everyday kind of thing, until they can bring the opioid really down and the LDN can take over.

And they have it by doing it so slowly, as you can imagine. Well, slowly by my thinking, um. Or, or rather fast by my thinking. They say it's slow, but it does seem to happen quite quickly where they get them off the opioids, and they have gone, they haven't gone through withdrawal, they haven't had any side effects.

And you know, the LDN, like you were saying, can be used in place of the opioids and give pain relief. It's just amazing to me that something so small that's not harmful or toxic or even expensive can work so well. 

John Herr: Yeah, it is amazing. I mean, I think we just, as I said, when I first started working with it, we just kind of thought of it for like autoimmune.

But how we, you know, now that we know that it's working on the immune system when we know it's working on, you know, with the upregulation of endorphins and we know that it's working on the toll like receptors for inflammation. And now that we see how it affects dopamine for depression, I just think the, I mean it's just amazing to me how many opportunities there are out there for physicians to learn how they can better treat their patients for numerous, you know, disease states,  

Linda Elsegood: and of course, most people that have an autoimmune condition, one of the underlying problems is the inflammation, isn't it?

So by reducing that inflammation alone helps the person feel so much better anyway, especially with the boost of endorphins as well. 

John Herr: Oh, yeah. Actually, my wife, who's a pharmacist, is a perfect example. Like she went and had all this blood work done in her, what they call her ANA level was through the roof.

So your traditional physician would look at that and say, Oh, you must have rheumatoid arthritis. Because she was getting, wasn't really achy joints, but she was getting pain, almost like fibromyalgia pain. So we knew it was inflammation, and at the same time, her blood pressure was uncontrollable. It was, you know, we actually had her on a heart monitor, and then one of the physicians that we work with, when they did, you know, we really started working more in-depth than they did the food allergies.

We found out she was severely allergic to dairy. So, you know, started her on, you know, obviously an elimination diet, and then low dose naltrexone, which she titrated up gradually to a dose about 4.5 milligrams, but the ANA level came down, you know, uh, you know, obviously with inflammation, all the inflammation markers went down. The pain went away. And the funny thing is like we had to get her off that blood pressure medication really quick. The pressure was just dropping. So now she's just on LDN and you know, obviously supplements and you know, dietary changes, but there's no more blood pressure medication needed, and she doesn't have the pain anymore.

So it's an example of, you know, the LDN is a tool, but you still have to take into account all of the other things that are going on. But the diet, nutrition, exercise, I always try to tell people it's a package deal. You know, the LDN is one of the most important pieces, but there are other things that you can do for your health.

Linda Elsegood: Oh, definitely. Um, I used to have to take, um, Omeprazole for Acid reflux, and if I didn't take it, I was in trouble. It's that severe, but by going gluten-free I now don't have any problems at all. I don't have to take the medication. I don't have any acid reflux at all. But if I go out to eat and you know what it's like you're going through the menu and say, you know, it doesn't look as though there'd be any gluten-free in this. Could you check with the chef for me? And they'll come back and say, no, there's no gluten in it. If there is, I don't sleep that night. The acid reflux is so bad. And I have to sit up. Right. If not, I'm just going to vomit. It's terrible. So I don't always believe people when they tell me there's no gluten, cause I know if there's any gluten in it.  Yeah. So it's amazing, isn't it? How you can just eliminate other medications just by diet. My husband has problems with these. The skin on his hands. He's allergic to milk, and he'd seen so many different doctors in the past, and nobody could tell him why the palms of his hands would go like white and dry.

But when he eliminates dairy, his skin is completely normal. And that was like 30 years of trying to find out what was wrong with his skin and never had an answer. . 

John Herr: Yeah, that's what I, my thing, when I'd give talks on this, I always tell people, patients, or if I'm talking to groups of physicians, you know, whoever it might be, I, I say at least I know in the United States, I say, we say that we're in healthcare in the United States, but we really are not.

We're in sick care, you know, our, our system in this country is, I hate to say it, but it's run by big pharma. So you know where our physicians are, a lot, many of them are trained to wait until the patient presents with the disease and then give a pharmaceutical remedy for that disease, whereas an integrative medicine, or you can take like LDN, I think, you know, we're trying to get at the underlying cause and how can we correct that so that we can live healthier.

Linda Elsegood: yes. It's, um, quite common for people to tell me that. The doctors are only treating their symptoms, but not the root cause. So of course, you then end up with all these medications and some people are taking in between 14 even 22 different medications a day, and some of those are only needed because of the cocktail of drugs that they're taking cause side effects.

But that's okay cause they'll give you another tablet which will combat the side effects from the cocktail you're taking. 

John Herr: Yeah. Well, I think Linda your example was the perfect example there. You know, that drug was originally made for somebody who had an active ulcer and then you theoretically would take it for, you know, two or three months, to allow it to heal and then change your diet and, and you know, go on. But now people just live on that drug, you know, the purple pill. It's like they have to take it forever, which you know, it affects, then you're affecting your gastric pH, your digestion. It's a slippery slope. I agree with you. 100% 

Linda Elsegood: Hmm.

And of course, I also have people telling me that it's expensive to eat healthily, and especially when you've got children, it seems. So sad, and I can understand if you only have a limited amount of money and you've got several children, they all need feeding. But - we call them crisps - you call them chips over there, and we have biscuits, you call them cookies, but you, you, you get where I'm coming from. That is cheaper than buying apples, some pears and bananas and oranges and such, which would be a healthier option. But the price difference is quite amazing, isn't it? And especially if you have. Uh, mass-produced meat from a supermarket or you're buying organic local meat or vegetables.

Uh, the price difference is quite high, isn't it.

John Herr: Oh, yeah. It's much harder to try and eat organic and healthy. You're right. And then you see the commercials where McDonald's is our friend. The dollar meal menu. Oh, please don't just don't even eat there. But do you want you to understand? Some people though, socioeconomics, they don't, they don't have that choice.

But you know, everybody can make little changes, I believe. Do you know? Uh, and then that's what we try to educate them on. And as you mentioned, I mean, just the cost of medication, like, uh, it's gotten, even when they're covered by insurance in our country, many patients can't afford their medications with their copays.

So I, whereas the low dose naltrexone, you know, I'm such a big believer in it. I, you know. Okay. I worked with Dr Dahda who, you know, explains to me that, you know, his patients are chronic pain patients. So a lot of them are, you know, disabled or they, you know, they don't have a large income. So, you know, we, you know, once we have them too, they're titrated to their dose that the dose that they're going to be on for their pain, then we dispense like a 90 day supply.

It, you know, at a cost that in most cases is lower than their copay. Uh, cause we just believe in the therapy so much that we want to, you know, help it help patients and make it available to them. 

Linda Elsegood: What about shelf life on your capsules? How long do they last? 

John Herr: Well, you know, the USP governs that in our country, so I imagine they would last longer, but where, you know, only allowed to put 180 days on, on there.

Once we, from the date that we make it now, certainly at the pharmacist, I think it would last a lot longer. But because it's compounded, you know, the USP United, which is the United States pharmacopoeia, which is basically overseen by the, you know, the FDA, the food and drug administration, and then that's up to 180.

Yeah, a day, what we call the beyond use date or expiration date. So that's what most people are getting a 90 day supply. They'll certainly going to fall within that date range.  

Linda Elsegood: I understand. And so that would be the same for the tablets as well once you start making those if that is the rules and regulations of the land. The 180 days?

John Herr: Yeah that’s correct that’s a solid dosage form and then once you go into anything that was a liquid, for example, um, now if you'd like for it to stop, I had to make it into for a young tile than a liquid format, you know, then we would be restricted, believe it or not, to a 14 day supply? You can also do testing, you know, so you can test that it's stable to extend that beyond use date. But most of the patients we see are, are using the, you know, the solid oral dosage forms, the capsules or the tablets. Yes. So it's usually not that much of a problem.  

Linda Elsegood: and what fillers do you use. 

John Herr: Well, typically, like most people, we use avicell, which is just an inert starch that people do not have any problems with.

But because we, we, you know, my pharmacy, it's, you know, we were only compounding. So we work with a lot of functional medicine and integrative practitioners. So we have a person who did have like what we call chemical sensitivities. A lot of times I don't think that they're going to be allergic to the, uh, you know, to the low dose naltrexone or it, but it could be the filler.

So sometimes what we'll do is we'll give them different filler. We might give them some avicill capsules, we might give them some acidipholis capsules, or sometimes we'll use a vitamin, you know, nutritional that we know that they can take. And then we'll have them take the, you know, capsule, you know, for about a week or so with actually, without, with no now trucks on it.

Just to make sure that they're not having any type of re, you know, reaction to the, uh, to the filler. So, you know, typically we do avicell, but you know, for specific patients, you know, if they have chemical sensitivity, we will adapt it too, you know, whatever will agree with that particular patient, especially if they practice kinesiology.

I have a couple patients and practitioners, you know, practising aetiology so they can kind of, sometimes they can tell which filters are, you know, will react to a patient even. Just from the, you know, if you understand, can aetiology, how it works in the body versus even half the taking it to see if they have a side effect.

Linda Elsegood: Okay. And what about the capsules? Are they sort of, um, a vegan free capsule? 

John Herr: Yes, we can get a, um, they're, they're a vegetable base, so now they're not a,  typically they come gelatin or, or, or vegetables. So we can, you know, we can get either, our goal is to go. At least eventually to the tablets once we, um, you don't have the tablet machine running correctly, but with the tablet you're, you know, unfortunately, you have to kind of make a couple of strengths.

It's not that you can go, oh, I can just run or, you know, or make a runoff, you know if it was a strange or an odd strength, you know, let me just make 30 or a hundred of that. What you have to do that in bigger batches, I don't think I will ever not be also making capsules. You said if you have the patients that need them, the ultra-low dose or patients who.

Everybody used to think it was 4.5 milligrams like religion, but now we know some patients do better with nine milligrams, some patients do better on three milligrams. So I envisioned that will always be, you know, compounding capsules. But we'll also, for those patients that are taking the more common dose, we'll have the availability of the, you know, tablets that we can keep up with the demand because you know, myself being, and.

in this metropolitan area of New York City, New Jersey. There are so many patients who need this, uh, need this treatment. 

Linda Elsegood: And what area do you cover? Um, before we started, you said the Manhattan area, so. Could you just explain exactly where you, you cover? 

John Herr: Oh, sure, sure. Yeah. And in the United States, uh, again, the FDA requires that you have to be licensed as a pharmacist in any state that you're going to send, you know, medication into and low dose naltrexone is considered a, you know, prescription medication in our country. So, you know, you have to be licensed in those States. So I, I've concentrated my licenses in the Northeast, so I, you know, work in areas such as, you know, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Ohio, Pennsylvania, Delaware, Maryland, you know, the, in this area of the Northeast.

But, uh, you know, previously I was president of IACT, which is the international Academy of compounding pharmacists. So I know pharmacists all over the country. And a lot of times I'll get a request for, you know, low dose naltrexone in another state. So I always know, you know, a good colleague that I can refer to that prescription to if no, if I get, I have a request and, uh, to state that I'm not licensed then.

And compounding pharmacists generally kinda like to network and share ideas with one another, which, you know, it's very collegial, which is something that, you know, really makes me enjoy the profession. So I do many instances I send prescriptions that I get to people I know in other States because I'm not licensed in that state, so we always try to make sure the patient gets their medication.

Linda Elsegood: And since you've been compounding LDN for so many years, has anybody ever reported to you any adverse effects that may be unusual? 

John Herr: I have like one patient and that she's come to like three of my seminars and her husband's a physician, but she just has a funny reaction to the naltrexone, and we've tried it.

We've tried ultra-low-dose and, and everything, but it really just upsets her, you know, upsets her stomach or her head. She just doesn't feel right on it. And I mean, she's tried it so many times because of it just, she's read so much about it, and her husband's been a practitioner. She's all one patient that's just tough to treat. But other than that, we get the typical side effects you see, which are the, uh, you know, the vivid dreams, the stomach upset, you know, maybe like a slight little headache. But typically we just work with those patients and tell them that you need to start the dose slowly and titrate up gradually.

So we've actually put together a, a, you know, like a titration kit. You know, for patients, cause many of the doctors don't realize that many doctors hear about low dose naltrexone and they just, you know, they think they can simply write a prescription for a four milligram or a 4.5 milligram. So we'll, we'll go in and educate those physicians that we have, this titration kit that we go up gradually once the patient gets to be on, you know, the dose that seems effective for he or she, well, they then compounded into that particular strength. So I think that's really helped a lot for patients to, you know, avoid the side effects and, uh, you know, get to their particular individualized dosage. 

Linda Elsegood: Well, I've been on LDN since 2003, and at that time over here anyway, we were given three milligrams for a month, and then you went on to 4.5, and that was it.

But the dropout rate was really high starting on three milligrams because we have found now that some people, you know, two milligrams is as high as they can go. So you can imagine starting on three it was a no go from the start, you know, it was far too high for them. But now, depending on what the condition is, It might be as low as 0.5 milligrams starting or 1.5 but doing it gradually and slowly. We find that not many people drop out of taking it. They seem to tolerate it really well and notice benefits quite quickly. 

John Herr: Oh, I agree with you, Linda. 100% on that. And then the other thing, like I always try to caution patients on it is that don't give up on it.

Because sometimes, even though maybe they didn't get any side effects, the patient thinks they're not getting the effects from the low dose naltrexone. And it's funny, we had two women, they were, you know, they were, you know, they were girlfriend, you know, and they both had a similar condition around the same age, and they went to the same physician, both started on the titration kit and, and the one woman that she got to 3.5 mg and she was just feeling wonderful. And the other lady kept going up and she got to like 4.5 and wasn't experiencing any, um, any relief from her. Uh, you know, what she was trying to treat,  but we just told her, you know, you gotta stick with it, stick with it. And you know, she was discouraged because the girlfriend was, you know, she was not even 30, you know, it's about 30 days. And she was feeling well, and she wasn't getting any benefit that she perceived. And lo and behold, it took four months.

And then she started to get the relief. So the other thing is like, even though you know you start low on the dose and titrate, which you know, we agree 100%, you also have to make sure that the patient realizes that sometimes you need it can take six months before the low dose naltrexone really start to show differences in their body.

And I always try to caution patients, you know, depending on the disease that they're trying to treat or the condition they're talking to trying to treat, I tell them, look, this didn't happen to you overnight. You know, this whole thing was probably going on your own, in your body for a long period of time.

So, you know, you're thinking traditional medicine, like, you know, you had a toothache and somebody gave you Tylenol with Codeine, and of course, it's going to work immediately. But with this, we're trying to upregulate your body and get your body to correct what's going on. So you do have to caution patients that, you know, give it time.

I usually recommend, give it a good six months before you say it's not doing anything for you.  

Linda Elsegood: well, we noticed, um, when we did a survey that some people said they had no symptom relief, but their disease stabilized. So I mean, that's a win in my book if you've managed to stop progression, but then between 15 and 18 months there was, um, 2% of people, whatever it was, didn't find symptom relief until they'd been taking it 15 to 18 months, which is a really long time. But they had stabilized before then. Um, and only 5% of people at that time or have any side effects at all. But the number of people who have stopped LDN because it probably wasn't working, or it was too expensive, but they stopped. And those people normally come back to me in about three, four weeks and say, in actual fact, the LDN was working for me. I'd forgotten that my bladder used to play up. I'd forgotten the pain that I had, “I’d forgotten …..”. You know, it wasn't until they'd stopped that they noticed that LDN in actual fact was working for them.

John Herr: yeah. I agree with that 100%. I've, you know, I've had like another woman, we would just counselling who hang out with her. Uh, you know, general, like almost like fibromyalgia pain and everything. Had ah It's totally a had gone away while she's been on the low dose naltrexone, but then all of a sudden she started to get pain in that.

And uh, you know, she's gotten real nervous. Like, Oh no, but I held the end isn't working for me anymore. I have to have this. This is how it is. This has been a miracle for me. What's going on? But then again, you know, functional, integrative medicine, when we talked to the patient with what's going on in your life, he starts to see that, Oh, you know, now you're going through, you know, you're right at the, into perimenopause, going into menopause, you have the pain.

Oh, it's right around my menstrual cycle. Okay, what's happening there? You're probably. Your estrogen level isn't where it used to be. And we know when women, particularly that when their estrogen and the estrodile goes down, they tend to get aches and pains. Hmm. So maybe it's a matter of, you know, adjusting your estrogen at this point.

It's not that the LDN stopped working, so you always have to look at your patients, and that's why the patient always has to go back and, uh, you know, consult with there, either their compounding pharmacist who can send them back to their physician or their physician. But it's not always just the, uh, you can't always blame it on the LDN.

Other things, you know, are happening in your life are happening with your body as, as we, as we age. So it's, uh, that's why I say it's a package. 

Linda Elsegood: I was asked a question this week, and a gentleman said,

it would appear on the forums that he's been reading that LDN doesn't work as well for men as it does for women. And was this a hormonal problem? Have you noticed it doesn't work as well for men as women, it seems, 

John Herr: you know, you're right. We have more of women that, uh, that are on low dose naltrexone, but I, I don't know why, but I thought like when we were talking pain, you know, certainly the, um, I think it works for both men and women equally well, but when we have other conditions such as fibromyalgia, that it makes you wonder, is it, is it also something going on with the hormones or, I think I have a great interest now in, in like Lyme disease and low dose naltrexone. And, and we know surely that Lyme disease, you know, uh, affects the pituitary, which is signalling in the body to produce hormones. And also, if you think about chronic pain, when people are in chronic pain, they're not producing their hormones the same.

So that's where I think we have to not just think that it's just a panacea and then we can just give low dose naltrexone, but we have to measure those patients hormone levels. And adjust them accordingly. So, and I think. You know, honestly, that may be what you, what you just elucidated is that you know, women will tend to, you know, go through menopause or their hormones will change at a much earlier age than men.

So, you know, for a woman, you know, we usually say around age 50 our hormones are trying to change. Men won't happen later on in life. So maybe it's not a difference, you know, in between males and females as much as, is it also something that has to do with the relationship between the hormonal changes.

And women getting them at an earlier age than then we're associating that more women do better than men, but reality maybe. Cause it's that man still has this testosterone in his body. 

Linda Elsegood: Oh, okay. It does. It does. And we're now out of time, but I have to have you back another day. We could have carried on talking there forever.

Could you tell people how they can contact you? 

John Herr: Well, certainly, uh, you can call us at our pharmacy directly, which is a 201 447 2020, and then you can always find us on the internet. Our, uh, pharmacy is https://tccompound.com/ and from there you can even email the pharmacist a question or, you know, call us directly.

And we just love talking to patients, and that's what we do. And we, and we do hold seminars, usually monthly on low dose naltrexone, which we will post on Facebook and on our website. And, you know, make people aware that if they're, you know, in the area that they can come in and see it. 

Linda Elsegood: Wow. Amazing. Well, thank you very much for all your hard work and for promoting LDN to your patients all these years.

Um, absolutely fantastic. And for educating people, so thank you very much. 

John Herr: Oh, thank you, Linda. I love talking with you and, uh, looking forward to doing it again. 

Linda Elsegood: Thank you.

At the town, a country compounding pharmacy in Ringwood, New Jersey, owner, pharmacist, John Herr and his team are passionate about low dose naltrexone. They have compounded LDN for over 15 years. And they're committed to compounding high-quality medications and serving as an educational resource for patients and practitioners alike.

Visit https://tccompound.com/

any questions or comments you may have. Please email me contact@ldnresearchtrust.org. I look forward to hearing from you. Thank you for joining us today. We really appreciate your company. Until next time, stay safe and keep well.

Pharmacist Kim Hansen, LDN Radio Show 30 Oct 2019 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today, my guest is pharmacist Kim Hansen. She's from the Town and Country Compounding Pharmacy in New Jersey. Thank you for joining us today, Kim. 

Pharmacist Kim Hansen: Oh, it's my pleasure. Thank you for having me. 

Linda Elsegood: So when did you first decide you wanted to become a pharmacist? Was it something you'd always wanted to do?

Pharmacist Kim Hansen: Absolutely.  I was working in a small independent pharmacy, a traditional retail pharmacy when I was in high school. And on occasion the pharmacist there would say, Hey, Kim, go mix these two creams. Or Hey Kim, go mix these two liquids. I was hooked. I knew that's exactly what I wanted to do. And from that point on I headed for pharmacy school and that was my path. I knew it immediately. That's what I wanted to do.  

Linda Elsegood: So where did you study?

Pharmacist Kim Hansen: Rutgers college of pharmacy in New Jersey. 

Linda Elsegood: So you haven't moved far? 

Pharmacist Kim Hansen: I've travelled far, but I haven't moved far. 

Linda Elsegood: So once you started compounding,  what were the main medications you were doing at that time?

Pharmacist Kim Hansen: Back in the day, it was usually combining a couple of creams together. That was before we had a lot of the manufactured products that we have now. A lot of times compounds start off that way, then they end up being manufactured items later. I used to have to make a topical minoxidil solution. I used to have to make up progesterone capsules way back in the day. Suppositories for progesterone. This was 20 some years ago. So it was before I knew of LDN.  I was doing compounding before that. Mostly progesterone and topical dermatological items that were not commercially available.

Linda Elsegood: How did you hear about LDN?

Pharmacist Kim Hansen: I think it was at a compounding seminar is the first time I'd ever heard of it. It was being discussed for autoimmune issues. I started seeing prescriptions for it about seven or eight years ago. Usually, it was just capsules, usually, it was the three different dose levels that we know differently now. It started gaining traction more for me within the last three years. But I did see it back seven or eight years ago.

Linda Elsegood: And what forms do you compound LDN into?

Pharmacist Kim Hansen: Right now we do capsules and oral suspensions. Most often it's the capsules that patients are happy with. We also do a cream for patients with autism, and occasionally it's added to pain gels as well.

Linda Elsegood: What is the filler of choice for people?

Pharmacist Kim Hansen: Generally speaking, patients are happy with acidophilus. I do have patients that don't want that. And then we usually use micro crystal and cellulose, but if they have a specific filler question or need, we're happy to accommodate that.

Linda Elsegood: And what strengths do you do now in the capsules? 

Pharmacist Kim Hansen: I think our lowest is a hundred microgram capsule because that patient prefers that to be in a capsule form versus the liquid form, anywhere up to 10 milligrams and anything in between. 

Linda Elsegood: And the patient population, what would you say the top conditions that LDN is treated for from your pharmacy? 

Pharmacist Kim Hansen: Hashimoto's, pain and depression. 

Linda Elsegood: So talk us through those three, Kim, the experience that you've seen from those patients. 

Pharmacist Kim Hansen: I'll start with Hashimoto's. We do notice patients are getting to a dose that is appropriate for them and are feeling better. They also require less thyroid hormone.

If someone is on thyroid hormone and start LDN, that should probably be monitored more closely than before you started the LDN, because you'll find that as the inflammation reduces, the thyroid level changes and you may need to change your dose. Usually, it's a reduction in the thyroid dose when it comes to the pain medication using it for that.

I have patients who have had their lives changed. They were in a tremendous amount of pain before, and they were put on other pain pills. Any medications usually were just adding to their pill burden, but not really giving them relief or quality of life that they were looking for. I have patients who weren't able to do any of their activities of daily life and now are doing things that they haven't done in 20 years. To me, that makes things tremendously rewarding to know we can be a part of that success story.  I should also mention when discussing pain with patients, I have patients who have become tolerant to opioids. So we also find that LDN is a way to help reduce the opioid burden and help people get off of those and still maintain their pain relief. I view those two things together like pain and sometimes patients are looking to get off the opioids for relief of their pain. So it actually does both. 

The other I  touched on was depression. I have patients who are using an increasing schedule of LDN and also weaning off usually their SSRI or antidepressant drug. And they're finding if they wean very slowly off the antidepressant and titrate upwards very slowly with the LDN, they're able to get off of the antidepressant and still maintain a non-depressed state. They're happy to be off the medication and be able to use LDN, which we know works in a different way and usually has a better overall effect than the actual medication worked for them. 

Linda Elsegood: Ultra-low-dose naltrexone helps combat the opioid crisis. Could you talk us through how, when people come to your pharmacy, whether it's been addicted to prescription drugs for many years, how LDN plays a part in getting them off the opioids, but still controlling the pain? 

Pharmacist Kim Hansen: I won't get into a specific schedule because it is so dependent on each patient. I will say that we usually start patients on the microdose or the low dose, ultra-low-dose naltrexone, usually in a suspension form, and they'll be on whatever their dose is usually for about a month. And then after they're stabilized with that, the pain management expert will slowly increase the dose of their ultra-low-dose naltrexone and also decrease their opioid dose usually by about 10%. Again I don't want to give schedules and hard limits because every patient is so different in their ability to reduce. It's very varied as far as that goes, but I have many patients who have been on rather strong doses of opioids that have been on that for years, have been able to slowly titrate up on the naltrexone and slowly wean down on the opioid and have had success and be pain-free and opioid-free. That's huge to have that happen. We had one hospice nurse  (certainly hospice nurses are very well versed in pain and pain origins and pain protocols) who herself had her own pain issue. We walked her through this process of slowly starting the ultra-low-dose naltrexone and scaling that up over time and reducing the dose of the opioid over time. Now she’s opioid-free and as pain-free. And it definitely helped her increase her quality of life and also to be able to do the things that she couldn't do before.

So that's a huge story. I mean, someone who is on opioids, to be opioid-free is huge. 

Linda Elsegood: Definitely. For people listening out there who are in a lot of pain, because I'm told nearly daily that there is somebody who is in terrible pain, but they were already on very high doses of an opioid that doesn't seem to be working, you know?  Of course, the problem with opioids is your body gets used to them, and you have to keep increasing the dose to get the effects you were having. So anybody who has chronic pain for whatever reason, or fibromyalgia or having an autoimmune disease that has a pain component to it, how would they go about.

finding a doctor who would prescribe LDN and one that would understand about the ultra-low dose, who would be able to help them transition from the opioids to the ultra-low dose?

Pharmacist Kim Hansen: Two awesome ways to find that out. One is LDN research trust. There are lists of physicians and practitioners on there that are knowledgeable in what we're talking about here. You can also ask your local compounding pharmacist because we are a treasure trove to know who is actually prescribing it in order to be able to send patients.

It works both ways. The prescriber sends the order to us as they know that we'll do a quality compounded product. I can then refer patients back to other practitioners because I know that they're knowledgeable in this and then they've attended our seminars and that we can work together with them in order to get the best outcome for the patients. So it works both ways.  

Linda Elsegood: I was quite surprised when Dr Sam was telling me how quick the process is because I thought it would be a long, slow process. But he was talking just a few weeks, which was, wow. People that had been on opioids for many years, to, find relief like that, it just amazes me that something.so small and so simple seems like tickling the pain with a feather in those ultra-low doses rather than using a really big mallet, which is the opioids, for it to work. It just is mind-blowing, isn't it? And of course, the price, LDN is not expensive, and many people have to pay for it themselves. And it's not a price out of the reach of most people. We still have people who do not have money, they're sick, they're not able to work. And if it's a choice between food or LDN, that's a problem. But we're looking at around $30 a month, depending on where you have it compounded. It's an affordable drug, isn't it? 

Pharmacist Kim Hansen: Absolutely. We try to maintain that because we do understand that patients are in pain and you don't want them to have to choose between therapy and their food or their bills or whatever that is. We want patients to get the relief that they need.

We've kept what we're doing affordable so that we can make sure that it's available to as many patients as possible. Usually, you'll find whatever pharmacy you use, if you're going to be starting a titration and working your way upwards, usually that pharmacy will put together a kit.

So you've got maybe two different doses of a capsule in there so that you can gradually increase to the dose that you are working towards. And then once you arrive at the dose that's working for you, then that pharmacy can make that dose into one pill so that it becomes more economical if that makes sense.

Linda Elsegood: Yeah. I had a lady email me this morning, I think she had Sjogren's syndrome, and she was doing really well. She'd worked up to three milligrams. It did really well. She's now on 4.5 and she's not sleeping,  not feeling as well. And I was trying to explain that with LDN it's not, the higher the dose, the better the benefit. It's what suits you best. And if at three milligrams, she felt really good, why would she need to go to 4.5? It's not working. It's making her feel ill, so she should go back to where she was in a good place. There is so much misinformation out there that people seem to think that this magic 4.5 is the goal that everybody should be on. Have you noticed that with your patients? 

Pharmacist Kim Hansen: Absolutely. I've had patients tell me the same story that you're describing here. Everybody has in their mind that more is better and that the goal is to get to a certain number because that's where the best results are.I am always cautious about making sure I explain to patients, hey, we're dispensing a kit to you. This initial kit is usually good for 49 days or seven weeks, but if at some point halfway through this kit, let one of us know that you're experiencing relief or you're not experiencing anything at all. If you are at a dose where it seems to be optimized, I don't want you to have to continue to go up because the goal isn't to make it more, the goal is to get relief, and if you're getting relief at a lower dose, then stay there because it's very easy to overshoot that and you'll lose the benefit. So, in this case, absolutely more is not better.

Linda Elsegood: Do you have any stories of people who are on a very low dose that have stuck to that's the right dose for them? 

Pharmacist Kim Hansen: Yes, a patient with diabetic neuropathy who was using the kit and they had gotten to a higher dose, and they weren't feeling so good on that. He backed off the dose he had gotten to, I think it was three milligrams. He went up to the next step, said I don't feel as good as I did on the dose before that. Then we know where you should be. And we had him go back to the dose he had come from,  he's much happier there, and he's able to function.

Whereas he was in pain and uncomfortable before. 

Linda Elsegood: What I was getting at there was, I know quite a few people that are on 1.5 or two, which I mean is low for low dose even, isn't it? People tend to think anything under three is no good, but even that is too high for some people. Not everybody gets there. As you were saying with the man with his diabetic neuropathy, you don't have to panic. Or thinking that you know you're not taking the right dose. I know some people think that it's not a therapeutic dose if it's under three, but that is a myth, isn't it? 

Pharmacist Kim Hansen: I would agree with that. Every patient is different and how they respond to it. So even if you have identical twins. A member of your trust that lectured about this, their one set of neighbours. They completely matched as people go, and the same age, same condition, same everything else. If you go down the line and, person A got results more quickly than person B. So person B was discouraged thinking that they weren't going to find the same relief that person A got.  Having to start over with patient B, and go a little bit more slowly, titration was the key for her. So whereas a lot of times you'll see dosage regimens that, every week we're going to increase by whatever the increment is. Sometimes patients will need to go even more slowly than that and maybe increasing every two weeks or maybe every month, whatever that takes. And again, not everyone is the same. So if you get to a dose rate, like, I didn't feel anything the whole way. Sometimes you can, wash it out, start over, and go more slowly and find results there. It's just so dependent on each patient and just because you haven't gotten the answer that you want and you've gone up to 4.5 sometimes the answer isn't going up a higher dose. Maybe it's starting over and going up at a slower pace.  

Linda Elsegood: Some people feel quite discouraged starting again, but by doing it very, very low and moving up very, very slowly the fallout rate isn't as high, and the success rate goes up. You know, 20% of people didn't have the relief they were looking for, but that 20% has reduced, hasn't it? We are getting a better success rate now, understanding there are people who do need to look at LDN differently. 

Pharmacist Kim Hansen: Completely agree. Back in the 80s when we were doing 1.5 and three and 4.5, that was such a rigid structure that you probably lost a lot of patients who didn't have success and or probably had side effects that they weren't pleased with. Changing our thinking with the results we have now, knowing that going more slowly and doing slower increases or lower increases is actually beneficial overall. Yes. Patients who have tried with not finding their success before; it doesn't mean you won't have success trying it in a different fashion.

Linda Elsegood: Exactly. And then there's the other school of thought where you have to take it at night. You know, it's not gonna work for you if you take it in the morning. We now know that's not true. Is that what your experience has been? 

Kim Hansen: I would say that's true.I think yes, at the beginning of the push was, Oh, you have to do it at night because your body does repair at night but you know, here's no reason why you can't do that during the day. And there are also reasons why you would want to do something twice a day and do split dosing. Some disease states and some patients do better when they're split dose.I find that is the case with using it for the antidepressant purposes, sometimes a split dose is better for that patient versus the whole dose at one time of day regardless of morning or evening. Again, individualized treatment, and you have to listen to the patient and listen to what they're saying to you so that you can work on a treatment plan together. 

Linda Elsegood: And you were saying about the topical cream for children with autism. Do you have many children with autism? 

Pharmacist Kim Hansen: We're in New Jersey, unfortunately, we have one of the highest percentages of autism in children. So yes, I do see it, not as often as I once did, but I do see it, and usually, they're not amenable to swallowing pills. So usually the parent is putting on cream at night when they go to sleep, and they don't even know what's being applied.

Even if they take a capsule and they put it into a smoothie or whatnot, kids are wise to that because they're probably on a whole bunch of stuff and they're eyeing up every meal that comes to them, making sure nothing's been hit, so they're pretty wise to it. You'll find that the cream is helpful in those cases and yes, it does work.

Linda Elsegood: And have you come across children with juvenile arthritis or pediatric Crohn’s who are taking LDN? 

Pharmacist Kim Hansen: I have heard of it, but not in my experience here. 

Linda Elsegood: And no children or adults with asthma allergies. 

Pharmacist Kim Hansen:  I had heard of it of course but no experience of that directly here.

Linda Elsegood:  It's amazing, isn't it? Initially, going back,15 and a half years when I started the trust, it was mainly people with MS. Then it went to Crohn's, then fibromyalgia, it was just exploding. But we didn't know too much at that point what it did for chronic pain that wasn't autoimmune. We knew it helped with cancers. We didn't know about all the mental health issues and of course, it's used in fertility clinics as well, and for women's health, for painful periods.  There's a name for that, PCOS, polycystic ovaries. Dr Phil Boyle uses it in his clinic to help women get pregnant. They take it during pregnancy, during breastfeeding, have really happy, contented babies, he says, and they have less chance of needing IV antibiotics for chest infections and things, which is apparently quite common in babies when they're firstborn. And he said, as a rule of thumb those babies are far more content when they come back for checkups,  than babies that haven't been exposed to LDN, which I think is quite interesting, isn't it? 

Pharmacist Kim Hansen: I agree completely with that. When I have a patient that's here, and I'm showing them the list of disease states or conditions that this is helpful for. And of course, their question is always, how could one thing be good for all of these? And I love that question because that means that you're thinking, okay. And you're sceptical, and that's fine, but then when you explain that a lot of these systems are all tied together and how pain and depression are linked by the same pathways as is your immune system, as are a lot of different things, inflammation, all tied together.

When you can explain and have them understand how the different systems in your body interplay, that's when the light bulb goes off because traditionally here in the United States you go to the foot doctor for your foot problem, you go to the GI doctor for your stomach problem, you go to the neurologist for the neurology problem. And really they're not all communicating.  When you look at the thread of symptoms that a patient is dealing with it's like you're missing the overall theme of inflammation or whatever that is. And LDN is helpful for that. So, therefore, it's helpful for all of those conditions. It's not because things are tied together. That's why it's helping you. I hope that made sense.

Linda Elsegood: It does. Now there are other things you can do to help inflammation as well as taking LDN. What do you suggest patients do?

Pharmacist Kim Hansen: For inflammation? Well, it's very important. I always remind patients that their diet is everything. If you look at the glycaemic index, it's scaled anywhere between zero and a hundred and sugar is at the top as being a hundred you would like to keep your dietary choices below a 50 because they are less likely to cause an insulin spike or have a glycaemic effect on your sugar. So if you keep your food items below a 50 more often than above 50 you're reducing the fire in your system. So the whole point of taking naltrexone is to reduce the fire in your body, as explained before.  Everything is connected. You can't expect the pill to do all of the work either. Reducing inflammation that you're adding to the system is also part of it.

You can't walk around eating the standard American diet of high carb and high sugar and poor nutritional value and not have inflammation if you're going to continue to feed the inflammation fire, of course, you're asking the LDN or the naltrexone to help with your symptoms.

Sometimes just reducing a lot of the inflammation that way is helpful and it certainly helps to augment what the LDN is doing. I also find that high-quality C-- products, the full spectrum ones are also helpful at reducing inflammation. Using the LDN in combination with the C--, you get the beneficial additive effects. I have patients who have needed to use that combination, and they've gotten their quality of life back.  

Linda Elsegood: it's funny what you were saying about fruits. My mother was in the hospital, and she was a type two diabetic, but her kidneys were in a very poor state, and she had to have insulin. She had quite a bit of insulin three or four times a day. When she was in the hospital, she asked for a banana. And they bought her a banana. And she said, Oh no, I, I don't like eating bananas a little green and underripe. I like them when the skin is going brown, and it's mottled and inside is all nice and squidgy. And they said, no, you can't have one like that because it's going to affect your insulin because it's very, very high in sugar when it's that ripe. That is correct. The nurse was trying to say very nicely, but it is higher in sugar, and I think my mother was thinking, a banana is a banana. The nurse was trying to say, you can have a banana but you mustn't have it when it's overripe.  Because it's too high in sugar. 

Pharmacist Kim Hansen: When I tried to talk to patients about that, of course, nobody ever wants to hear they have to make changes and give up their banana or wherever it is they're eating. Everybody likes what they eat, but when you explain it and say, Hey, these are inflammatory, what you're doing is adding to your inflammatory burden.  I'm not saying completely avoid the bananas, but if you know that you had had a banana that day cause you had to have it, maybe look at the bottom of the list to make sure that maybe we're balancing that out and making a choice that has less of a glycemic load than maybe the banana or something else. That's not to say that you should never have banana again, but maybe making choices to balance out your day versus choosing everything above 50 if you reduce the amount. Because they are both 50 and take below 50 reducing the amount of inflammation in your system, which is good for all sorts of things, Alzheimer's, heart disease, cancer risk, all of these things driven by inflammation. And why would you not want to reduce those risks? 

Linda Elsegood:  It's altering the way you look at food. Instead of being a diet which people don't stick to. It has to be a lifestyle change, doesn't it?  So it becomes a habit. You know you have good habits instead of bad habits. 

Pharmacist Kim Hansen: Agreed. If you call it a diet, people assume that is a restriction on their lifestyle. If it is health maintenance and it's on a different connotation or inflammation reduction. If you look at it that way, rather than, oh, I'm on a diet. Well, you know what? I'm trying to reduce the inflammation in my body. You'll find that you'll get fewer headaches if you get rid of sugar and carbs, which of course includes bread. There are healthier slices of bread that you can eat, more of the whole grains here.  I was amazed by this too. Everybody's under the misconception that, Oh well I, you know, I'll avoid the white bread cause I know that's not good for me and I'll just eat the wheat bread. It's no better. It really isn't any better. It's like a point or two different on this scale. What you need to do is either do it like a whole grain bread or switch to something that's grain-free, like Ezekiel bread, which has a low-glycemic index. If you're trying to make that effort, there are smarter choices that you can make.

So you don't feel like you're on a diet where you're restricted and being punished. There are ways to explain things.. You just have to be careful about continuing to pile inflammatory product after inflammatory product. It leads to all of the other health problems that I mentioned before.

We're all leading stressful lives, and probably you're not exercising as you should, and not resting as you should, and you're just adding more and more burden to your system to be able to detoxify. Helping your body do its best is certainly a better management tool all around.

Linda Elsegood: Well we've run out of time Kim, can you believe that's 30 minutes gone?

Pharmacist Kim Hansen:  I can't believe you wanted to listen to me. Wow. I'm so happy. 

Linda Elsegood:  Awesome. Thank you so much for having joined us. I really appreciate it. 

Pharmacist Kim Hansen: I'm so grateful to have been asked, and it's my pleasure. If you have any questions, certainly please give me a call and I'm happy to share anything I know. 

Linda Elsegood: Thank you.

At Town and Country Compounding Pharmacy in Ridgewood, New Jersey, owner, pharmacist, John and his team are passionate about low dose naltrexone. They have compounded LDN for over 15 years. And they're committed to compounding high-quality medications and serving as an educational resource for patients and practitioners alike. Visit https://tccompound.com/ or call (201) 447-2020 with any questions or comments you may have. Please email me at ontact@ldnresearchtrust.org. I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.

Norman Marcus, MD - 10th October 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today my guest is Dr Norman Marcus, who is a pain specialist. He has a fantastic background. Thank you for joining us today, Dr Marcus.

Norman Marcus, MD: Thank you for inviting me. 

Linda Elsegood: Could you give us your background, please?

Norman Marcus, MD: After attending medical school, I did an internship. In the old days, it was a rotating internship where I went through the various aspects of what a doctor might do. I decided to go on to do a residency in psychiatry. And when I was doing that, I, became very interested in mind, body interaction and following my residency, I did a fellowship in psychosomatic medicine.

While I was doing my fellowship, I was asked by the department of neurology at the headache unit where I was, at Montefiore hospital (they had the first headache unit in the world). I was asked to join them. They were treating patients with headaches in the department of neurology.and at that time I was interested in biofeedback because of the whole issue of mind, body interaction. So I started to evaluate patients with headaches and treat them with medication as well as the biofeedback. And at that time I was elected president of the New York State biofeedback society.

Following a few years doing that, I was asked by the department of anesthesiology to start the first pain centre in New York City in the department of anesthesiology. And I did that with a colleague, an anesthesiologist. And we together started and then ran together the pain centre at Montefiore hospital, which I did for approximately seven years.We had a multidisciplinary program where we're teaching patients how to manage their pain using nerve blocks at times and medication and psychological interventions and relaxation training. And then from there, I was asked by the department of medicine at Lenox Hill hospital to start an inpatient pain treatment program, which I did. That ran that for about 20 years. Then while I was there,  I was asked by the princess Margaret hospital  in Windsor to start a pain centre. And I started to travel to the UK, one week a month for three years. I have an appointment in Indian NHS, and I ran the pain centre there.

And while there, we got some significant publicity and we were on the BBC, BBC two, and we were on numerous television and radio programs. And  we were able to help patients who had persistent pain. And by that time, I was starting to focus on soft tissue.I was introduced to Hans Kraus, who was President Kennedy's physician for his back and France Kraus  had a.

technique and the conceptual model on assessing soft tissue pain, muscle pain, and the president at that time was being treated by another physician, Janet Trevell, and she was injecting Kennedy five or six times a day into his muscles.

When Hans Kraus came in he stopped the injections completely and said that the problem wasn't all the muscles that needed to be injected, but rather muscles that were very deconditioned as well as maybe some muscles that needed injections.But think of all muscles that are tender as a target for injection, like dry needling or something like that, didn't make any sense. And he had a conceptual model where there were four reasons for muscle pain. Tension is the number one, then a deficiency or otherwise known as weakness and or stiffness of key postural muscles. The third was the spasm, which is involuntary contraction of the muscle that you can't straighten up and it's very painful. And the fourth was altered muscle tissue called trigger points in most jargon when we're talking about these tender spots. But actually, Dr Krause's concept was more than trigger points cause he recognized that the area of the muscle.

that was causing pain, wasn't really in the muscle in the tissue, but rather the ends of the muscle where the muscle attaches to the tendon and the tendon attached to the bone is the most tender spot. It connected to that muscle, and that one needs to be identified. Therefore, the specific muscle that's finding a spot on your body isn't sufficient because the pain isn't.

generated from that spot. It's rather generated from the ends of the muscles, so you must know which muscle you're in. So he made that distinction. And his results when he would inject the ends of a muscle were dramatic insofar as he wouldn't have to re-inject the muscle. So the standard of care now in terms of people who were doing, let's say, dry needling or trigger point injections is to repeat the injections over and over again, quite often into the same muscle whereas Dr. Krause would be able to eliminate the pain by finding the muscle specifically and then going to the ends of the muscle and doing his protocol, which involved not only injections.

And what he used a lighter cane, just for comfort. He, it was the actual needle in the tissue that was doing the treatment. And following that, there's a three-day protocol, using neuromuscular electrical stimulation and exercises that were developed at Columbia University school of medicine in the late fifties, early sixties.

And  exercises were developed by studying 3,700 patients for four and a half years. And then he came up with an exercise program that he then administered to 300,000 people at the YMCA and studied twelve thousand of those patients in town who had an 80% success rate in diminishing or eliminating back pain.

And in patients who had had surgery for the back and had pain afterwards, that success rate was even higher. It was 82%. So those exercises then became the standard exercise at the YMCA called the Wise Ways to a healthy back. And they were given for many years until someone decided to change it. And without going into what actually happened, this essentially killed the whole awareness of these exercises, but we use them as a routine, part of the work that I'm doing. 

So when patients come in who have soft tissue pain, we diagnose one of these four mechanisms such as tension. John Sarno would be speaking about tension myositis.And now we know that there are mechanisms where if you are tense, it alters the neurons and your spinal cord  and makes them more sensitive to input sensitization. So we also test them for weakness or stiffness using the test that Hans Cross developed with his colleagues on your Weber called the Krauss Weber test. It's a very simple test, takes about two minutes  to implement. It gives you a lot of information.  They were palpating for tenderness in muscles to identify the muscle. And what happened was that I discovered  it wasn't specific enough that many people have tender spots throughout their body that don't necessarily reflect where the pain originates.

So you can have a tender point, and it may not be actually coming from there. It may be referred from another muscle, and it's almost impossible to know if you're pressing on a referral pattern or the actual pattern itself. I mean the actual muscle itself causing it, or where is this just a muscle that is receiving information from another muscle and all of this.

A complication of where the pain originates was explained to me by Sigfried Mensa. So I really began to understand what was going on on a cellular level, and on a biochemical level, through the work of professor Mincey and together, ultimately, we wrote a chapter together in a Harvard textbook. Carol Warfield is one of the editors of the textbook, and it came out a couple of years ago on the pathophysiology of muscle pain. In that period of time  I was elected president to the American Academy of Pain Medicine and served on multiple committees and became interested in how diverse the various treatments are for the pains that people complain of. 

I started the outcomes—movement in pain. To try to come up with some assessment where we could measure if a certain treatment was superior to another treatment, and that's been a work in progress for the whole pain community. It was something that I began  and we did our best to finish it, but it's still happening. And now it's a major goal and mission of NIH to come up with parameters to measure what is successful, outcomes and pain. And I've written a couple of chapters in neurosurgical textbooks on that.  Montefiore went to Lenox Hill hospital and then I left Lenox Hill hospital and went to NYU and became the director of clinical muscle pain there in the department of anesthesiology and taught students who were fellows in the Pain fellowship department of anesthesiology for ten years or so. In the last two years, I moved to Cornell where I have an appointment in neurological surgery and in anesthesiology, I'm the director of clinical muscle pain research, and I'm working together withmy colleagues and anaesthesia and neurosurgery to see how we can better define how soft tissue is an important element in patients who are coming in with a run of the mill back pain. And also those patients who are found to have a surgical indication for their back pain, but continue to have pain, despite a spot, an apparently successful surgical intervention.Why are they still in pain? And quite often it's because there's a soft tissue that was not identified as a source of pain. 

I was beginning  to tell you about the problems in identifying a specific muscle by pressing on it.  I've discovered that I could stimulate the muscles with a tiny amount of electricity, and I could much more accurately identify which muscle is the source of pain.I'm now working on a next-generation device with the Cornell school of engineering, the Meineke school of biomedical engineering, to develop an instrument where we can, have a software program that will show the clinician what are the various muscles in the body, in a region of which the patient complains of pain.

For example, if you have shoulder pain to 16 muscles that cause pain in your shoulder, how do you know which muscle is causing the pain? You don't, by pressing, you don't really know, but when we stimulate it with a tiny amount of electricity, and that particular muscle or a couple of muscles are painful, and the rest are not. Then we assume that those muscles are sensitized and are indeed the pain generator. And when we treat those muscles, generally we can eliminate the pain in the region of the body. For example, in that case, it would be the shoulder.  I had a patient who was coming to see me for knee pain, and this was about ten years ago or so, and he had 14 knee surgeries with the same orthopaedic surgeon, and every time she had  knee surgery, she continued to have pain afterwards, and she was given more.

opioid. In this case, it was oxycodone, and when finally she was receiving something like 3000 milligrams a day of oxycodone, a huge dose. 

She was coming in periodically for pain medication and she was functioning.although it was a huge dose and I wasn't entirely happy with it. But she was functioning and she had this extraordinary amount of medication and she would come in periodically, every month or so, and I'd renew the medication and then she didn't show up on one day. And I called her home, and her husband told me that she was hospitalized and said, well, what happened? Well, she had taken her medication and then she had taken an antianxiety drug, and she fell asleep in the bathtub and almost drowned and was admitted to the psychiatric unit of a hospital with supposedly a suicide attempt.

So I said, Oh my God, I was there and it was terrible. She was finally discharged, but spent about ten days there and then called me up, made an appointment, and she came in, and I said, how are you doing? She said I'm actually doing okay. I said, well, how's your knee pain?  She said I don't have any knee pain. Really? I said, well, you know, how much medication are you taking? She says I'm not taking any medication. Wow. You were 3000 milligrams a day.  So I said, well, what happened? So she said, well, there was this doctor who was there on this staff, his name is Hugo Franco. And he came in and  gave me some medication, actually gave me some naltrexone, and that helped me get off the medication so that I was able to go down to zero in 10 days.

So I said, Oh, would she have a lot of withdrawal? She said no, I had no withdrawal. So this is impossible. I mean, it's like one of these events saying, Oh my God, how could this possibly be? So I said, I'm going to call up Hugo Franco, and I did, which subsequently we became friends, and then he explained to me that he used naltrexone in an ultra-low dose to detox patients.

So much against what you know, was on the internet, for example, or, you know, never give naltrexone when somebody was on opioids, it was great because he explained to me that it actually made the opioids stronger if you gave it in tiny, tiny doses so that with a more potent effect, you could then start to decrease it because you were getting the same effect with lower doses and you could just keep on going down, which he did.

This was amazing for me. So I said, well, perhaps, this could be useful with other patients. So I started to use it with patients where I wanted to facilitate a reduction in dosage or to get them off of opioids completely. And I was able to successfully use it in that fashion. But I still idn't quite understand how it was working until I went to a lecture by Linda Watkins and, she explained the whole phenomenon of microglia and toll-like receptor number four and how the ultra-low-dose naltrexone wasn't blocking the mule receptor. And I hope that your audience understands that.

So the mule receptor is where most of the action is when you're using an opioid and pain pathways. The major factor when you have chronic pain, microglia become very important. And the receptor that becomes stimulated on the micro clear is called like receptor number four.

And when it's stimulated, it produces cytokines. 

 And many of these cytokines are pro-inflammatory, meaning they cause inflammation, particularly interleukin one and interleukin six. So these cytokines end up giving you neuroinflammation. It's sort of making more pain, pain on top of pain.it also gives you what's called illness, behaviour or sickness behaviour where you feel you don't want to interact with other people. You feel sluggish, you want to just retreat alone, sleep a lot. And it's like a survival mechanism. So if there was true trauma or you know, some injury in your body, the microglia respond by giving you these cytokines or producing these cytokines that make you want to just rest a lot and not interact and not waste your energy using all your energy for repair.

So I started to understand that the whole issue of central sensitization, which is what happens when patients have persistent pain. The issue isn't—all the receptors. We used to think it was that it was upregulation of the receptors so that you  needed more medication, because of the new receptor.But it was very much involved with the activation of microglia and that if we could suppress the microglia, we could suppress pain and actually reduce tolerance. That's some of the tolerance was a function of activating microglia. So I started to understand it would work for patients who had  central sensitization.t I've been treating a large number of patients for the earliest endless syndrome, and the most common complaint in that population is fatigue and pain.

When you examine them using my electrical instrument, they come up with anywhere from around 50 tender or sensitized muscles test positive. When I say the relatively normal population who just comes in, let's say with that pain, the average number of muscles, it's about five, so they have ten times the number of muscles that are sensitive to a small amount of electrical stimulation.And it would appear that they have central sensitization, because they are, sensitive to all stimuli, they do have a mood disorder and quite often they have something else that fits in the whole picture, which is mast cell activation syndrome. This is like another part of the puzzle that the mast cells, which are cells in the body that respond to trauma and to infection, to any assault in the body or to a foreign body,  they sometimes become overactive.

And the whole phenomena of overactive mast cells  hasn't been recognized until quite recently. Itt turns out that patients  understand that syndrome. A large number of them have mast cell activation syndrome, which is the abundant number of mast cells. Not too many, but rather a normal number of mast cells. But the mast cells are over-producing the chemicals that they produce, and they can produce up to 200 different molecules, and you can get many different kinds of  symptoms  but commonly would be, skin sensitivity, rashes, environmental allergies, GI problems with constipation or diarrhoea.

What’s  commonly known as irritable bowel syndrome, asthmatic like problems or rapid heartbeat, a rapid heartbeat when you're getting up quickly called POTS, postural orthostatic tachycardia syndrome, or sometimes orthostatic hypertension, migraine headaches. So we see these kinds of  symptoms and the mast cells also activate the microglia. 

So in terms of my practice, you know, getting back to ultra-low-dose naltrexone, that I would say almost all the patients I see I put on two ultra-low dose naltrexone. It takes a while to titrate up because we know that the dose to 4.5 milligrams for some patients is a total overdose and they will not be able to tolerate that. And this was actually taught to me by Dr Franco, my friend. So we start at 0.1 milligrams per day, and we go up by 0.1 milligrams every other day, in divided doses.. So it's not one dose at night, but rather four times a day dosing. So it would be 0.1 then three days on the third day, it will be 0.1 twice a day. On the fifth day or sixth day, it will be 0.13 times a day. Then a couple of days after that 0.14 times a day and then start again from the 0.1 so it would be the point to 0.1 0.1 0.1 then 0.2 0.2 0.1 0.1 and going up like that until we get to the maximum of somewhere between five and six milligrams a day as a maximum dose.

So we have some patients whose total daily dose is 0.15 milligrams a day. Total daily dose, and we have other patients where the total dose is six milligrams a day. So what's the dose for ultra-low-dose naltrexone? There is no dose. It's completely idiosyncratic, meaning each patient has their dose, whatever that may be. And so. I didn't stop talking for a long time.

Linda Elsegood: That is absolutely amazing, and you have wrapped it up in 30 minutes. We're going to have to have you come back and talk to us again because I'm sure you  just got started in that 30 minutes. So I'd like to say thank you very much for having joined us today. I really do appreciate it. 

Norman Marcus M.D. My pleasure.

Linda Elsegood: This show is sponsored by Dixon's Chemist, who are the experts in LDN at associated treatments in the UK. Dixon's Chemist, the most cost-effective for LDN in all forms within the UK and Europe. You are maintaining safety standards in  excess of what is required. Why would you choose to get your LDN from anywhere else?

Cool. 0141404654 five today to speak to the LTN experts

Linda Elsegood:Any questions or comments you may have, please email me at lindaa@ldnrt.org I look forward to hearing from you. Thank you for joining us today. We really appreciated your company. Until next time, stay safe and keep well.

Dr John Kim MD – 5th September 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr John Kim shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr John Kim has great experience with LDN and shares his latest results in combining ULDN (Ultra-Low Dose Naltrexone) with acupuncture and Vitamin C.

His chemical background allows him to understand the various pathways and how his treatments are working. He explains what ULDN is and how these micro-doses of Naltrexone can help people with high sensitivity to drugs. It can also be utilized to enhance the effects of opioids while reducing the dependence, and eventually replacing them to reduce pain. 

This is a summary of Dr John Kim’s interview. Please listen to the rest of Dr John Kim’s story by clicking on the video above.